EVOLUS, INC. Prepaid Expense and Other Assets, Current
EVOLUS, INC. (EOLS) had Prepaid Expense and Other Assets, Current of $7.02 million as of 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2021-03-25
- 2020-12-31: Prepaid Expense and Other Assets, Current $7.02M.
- 2020-09-30: Prepaid Expense and Other Assets, Current $6.01M.
- 2020-06-30: Prepaid Expense and Other Assets, Current $4.25M.
- 2020-03-31: Prepaid Expense and Other Assets, Current $3.56M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2020-12-31 | $7.02M 10-K · filed 2021-03-25 |
| 2020-09-30 | $6.01M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $4.25M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $3.56M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $5.33M 10-K · filed 2021-03-25 |
| 2019-09-30 | $3.91M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $2.96M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $2.83M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $1.18M 10-K · filed 2020-02-25 |
| 2018-09-30 | $924.00K 10-Q · filed 2018-11-05 |
| 2018-06-30 | $1.04M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $541.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $185.00K 10-K · filed 2019-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |